KANZHUN LIMITED Announces Second Quarter 2024 Financial Results
August 28, 2024 07:10 ET
|
Kanzhun Limited
BEIJING, Aug. 28, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited...
PLBY to Participate at the Lake Street Best Ideas Growth Conference on September 12, 2024
August 28, 2024 07:00 ET
|
PLBY Group, Inc.
LOS ANGELES, Aug. 28, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY), a leading lifestyle company and owner of Playboy, today announced that management will present at the Lake Street...
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)
August 28, 2024 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Oral presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant improvement in primary...
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2024 07:00 ET
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Lotus Technology Reports Unaudited Second Quarter and First Half 2024 Financial Results
August 28, 2024 07:00 ET
|
Lotus Technology Inc.
Robust start in 2024, marking the strongest first half-year performance in the brand’s history.Balanced global allocation, with strong US deliveries1 contribution after the brand’s re-entry into the...
5E Advanced Materials to Host Fourth Quarter Conference Call for Fiscal Year 2024
August 28, 2024 07:00 ET
|
5E Advanced Materials, Inc.
HESPERIA, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical...
Atea Pharmaceuticals Announces Publication of Additional Data Further Highlighting Bemnifosbuvir’s Metabolic Activation Pathway
August 28, 2024 07:00 ET
|
Atea Pharmaceuticals, Inc.
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral...
FactSet Schedules Fourth Quarter 2024 Earnings Call
August 28, 2024 07:00 ET
|
FactSet Research Systems Inc.
NORWALK, Conn., Aug. 28, 2024 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, announced today that it will release its...
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
August 28, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using...
EDAP Reports Second Quarter 2024 Financial Results
August 28, 2024 07:00 ET
|
EDAP TMS S.A.
Record Q2 2024 total worldwide revenue of EUR 15.8 million (USD 17.0 million) increased 10.6% over Q2 2023Record first half 2024 total worldwide revenue of EUR 30.7 million (USD...